NPPM
AGN

North Point Portfolio Managers’s Allergan Inc AGN Stock Holding History

North Point Portfolio Managers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-107,912
Closed -$22.9M – 86
2014
Q4 		$22.9M Buy
107,912
+755
+0.7% +$150K 4.37% 1
2014
Q3 		$19.1M Buy
107,157
+9,227
+9% +$1.53M 3.83% 2
2014
Q2 		$16.6M Sell
97,930
-10,107
-9% -$1.57M 3.33% 4
2014
Q1 		$13.4M Buy
108,037
+1,491
+1% +$182K 2.84% 10
2013
Q4 		$11.8M Buy
106,546
+1,097
+1% +$105K 2.52% 18
2013
Q3 		$9.54M Buy
105,449
+95
+0.1% +$8.53K 2.25% 24
2013
Q2 		$8.88M Buy
+105,354
New +$10.9M 2.23% 23

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

North Point Portfolio Managers's AGN Position: Q1 2015 in Review

North Point Portfolio Managers sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 107,912 shares — an estimated $22.9M sold.

North Point Portfolio Managers first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $22.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • North Point Portfolio Managers reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • North Point Portfolio Managers sold 107,912 Allergan Inc shares in Q1 2015, an estimated $22.9M.
  • North Point Portfolio Managers first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • North Point Portfolio Managers's Allergan Inc position peaked at $22.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on North Point Portfolio Managers's 13F filing for Q1 2015, filed 29 Apr 2015.